- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
When Cultures Stay Negative, Why Do Antibiotics Continue in Preterm Infants?

A study of very low birth weight infants highlights variation in antibiotic duration and calls for clearer clinical reasons when treatment continues beyond 48 hours.
When a premature infant develops signs of possible sepsis, antibiotics are often started before culture results become available. The harder decision may come two days later, when cultures remain negative but concern about missing infection makes clinicians reluctant to stop treatment.
A study published online in The Journal of Pediatrics in September 2026 examines how these decisions relate to measured illness severity. Star Liu and colleagues found that prolonged antibiotic courses after culture-negative evaluations for late-onset sepsis were not consistently associated with greater organ dysfunction.
The researchers reviewed electronic health records from three neonatal intensive care units within the Johns Hopkins Health System between June 2016 and April 2026. Eligible infants were born before 33 weeks’ gestation, weighed less than 1,500 grams and underwent sepsis evaluation at least 72 hours after birth.
None had received systemic antibiotics during the preceding 48 hours. Infants with positive relevant cultures, necrotising enterocolitis or death during hospitalisation were excluded.
The analysis included 202 initial culture-negative evaluations. Antibiotics were given for 48 hours or less in 122 cases and continued longer in 80, representing almost 40% of initial episodes.
Median treatment duration was 37.5 hours in the shorter-course group and 115.5 hours in the longer-course group. Another 109 culture-negative evaluations occurred subsequently in 48 infants.
To assess physiological severity, the investigators used the neonatal Sequential Organ Failure Assessment, or nSOFA, score. This captures respiratory, cardiovascular and platelet-related dysfunction. They examined scores before culture collection and during the following 48 hours, alongside available laboratory measurements.
Greater measured organ dysfunction did not consistently correspond to longer treatment. Cumulative nSOFA scores over the first 48 hours were not significantly different between the duration groups.
Several laboratory measurements were also similar. C-reactive protein was higher among initial episodes treated beyond 48 hours, although substantial missing laboratory data limited interpretation.
Computer models using the available clinical information likewise struggled to distinguish shorter from longer antibiotic courses. These findings suggest that structured physiological measurements did not adequately explain the observed prescribing decisions.
This does not mean that individual treatment decisions were inappropriate. Examination findings, concern about a localised infection, doubts about culture sampling or subtle changes recognised by bedside staff may influence treatment without being fully captured in structured records.
A negative culture must therefore be interpreted alongside the clinical picture. The nSOFA score measures organ dysfunction; it does not diagnose infection or provide a validated rule for stopping antibiotics.
The study also has important limitations. It was retrospective, involved one health system and excluded infants who died. It did not determine whether culture-negative infection was truly present or establish that stopping antibiotics at 48 hours was safe for every infant. Its findings identify a gap in understanding prescribing decisions rather than demonstrating that one treatment duration produces better patient outcomes.
For practising paediatricians and neonatal teams, the findings support a deliberate reassessment when cultures remain negative. The infant’s progress, sampling adequacy and any persisting infectious focus should guide the next step. When antibiotics continue, the reason and next review point should be documented. Prompt treatment remains essential when sepsis is suspected, but continued treatment deserves equally careful reasoning.
Dr. Khushboo Nagdev is a Consultant Physician and Diabetologist at Sanjeevan Hospital. She has previously worked as an Attending Consultant in the Department of Internal Medicine and Critical Care. Her areas of expertise include internal medicine, diabetes management, critical care, and the diagnosis and management of various medical conditions.

